BRX 0.25 (Rexulti 0.25 mg)
Generic Name: brexpiprazole
Pill with imprint BRX 0.25 is Brown, Round and has been identified as Rexulti 0.25 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.
Rexulti is used in the treatment of major depressive disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BRX 0.25
Rexulti
- Generic Name
- brexpiprazole
- Imprint
- BRX 0.25
- Strength
- 0.25 mg
- Color
- Brown
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Otsuka Pharmaceutical Co., Ltd. and Lundbeck
- National Drug Code (NDC)
- 59148-0035
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
microcrystalline cellulose,
magnesium stearate,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about Rexulti (brexpiprazole)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (364)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: atypical antipsychotics
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.